BIOMAT Database Logo BIOMAT Database Logo

[Alpha 1-antitrypsin (A-1-AT) level in bronchial asthma]. 1980

K Szulczyńska, and Z Zbytniewski, and A Kanclerz

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

K Szulczyńska, and Z Zbytniewski, and A Kanclerz
Serum alpha 1-antitrypsin in bronchial asthma.
April 1974, The American review of respiratory disease,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
Alpha 1-antitrypsin phenotypes and bronchial asthma.
June 1994, Chest,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
[Alpha 1-antitrypsin in children with bronchial asthma].
January 1981, Padiatrie und Grenzgebiete,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
Alpha-1 antitrypsin enzyme deficiency in bronchial asthma: a preliminary study.
July 1977, The Journal of the Association of Physicians of India,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
[Alpha 1-antitrypsin content in bronchial asthma patients undergoing immunosuppressive therapy].
February 1982, Vrachebnoe delo,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
Serum antitrypsin activity and alpha1 antitrypsin level in atopic bronchial asthma.
January 1978, Archivum immunologiae et therapiae experimentalis,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
Determination of alpha-1 antitrypsin level in patients with severe asthma.
January 2013, Tanaffos,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
Alpha-1 antitrypsin in childhood asthma.
January 1977, The Journal of allergy and clinical immunology,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
[alpha 1-Antitrypsin (alpha 1-AT)].
February 1995, Nihon rinsho. Japanese journal of clinical medicine,
K Szulczyńska, and Z Zbytniewski, and A Kanclerz
[Alpha 1-antitrypsin (alpha 1-AT)].
August 1999, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!